For chronic myeloid leukemia (CML) patients, there is a promising new first-line drug approval with asciminib (brand name ...
The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic ...
Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by ...
Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...
Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical has received approval from the U.S. FDA to commence Phase I ...
The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...
Opens in a new tab or window Share on X ... Notably, the FDA this year granted accelerated approval to two other drugs -- ...
In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...
If companies fail to promptly undertake confirmatory trials post-approval, this could compromise the robustness of evidence ...
A new BLA for datopotamab deruxtecan aims for FDA accelerated approval to treat EGFR-mutated NSCLC based on data from ...
Some pet owners want a recall of a new arthritis drug for cats after their animals died, some in horrific ways, just days ...